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GRB2 is a ubiquitously expressed adaptor protein required for signaling downstream of
multiple receptors.To address the role of GRB2 in receptor-mediated signaling, the expres-
sion of GRB2 was suppressed in human CD4+T cells and its role downstream of theT cell
receptor (TCR) was examined. Interestingly, GRB2 deficientT cells had enhanced signaling
from complexes containing the TCR. However, GRB2 deficient T cells had substantially
reduced production of IL-2 and IFN-γ. This defect was attributed to diminished formation
of linker for activation of T cells (LAT) signaling clusters, which resulted in reduced MAP
kinase activation, calcium flux, and PLC-γ1 recruitment to LAT signaling clusters. Add back
of wild-type GRB2, but not a novel N-terminal SH3 domain mutant, rescued LAT microclus-
ter formation, calcium mobilization, and cytokine release, providing the first direct evidence
that GRB2, and its ability to bind to SH3 domain ligands, is required for establishing LAT
microclusters. Our data demonstrate that the ability of GRB2 to facilitate protein clusters
is equally important in regulating TCR-mediated functions as its capacity to recruit effec-
tor proteins. This highlights that GRB2 regulates signaling downstream of adaptors and
receptors by both recruiting effector proteins and regulating the formation of signaling
complexes.
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INTRODUCTION
The ubiquitously expressed adaptor protein GRB2 facilitates the
assembly of multiprotein signaling complexes at activated recep-
tors and signaling proteins. GRB2 and its homologs, GRB2 related
adaptor protein (GRAP) and GRB2-related adaptor protein down-
stream of SHC (GADS), are composed of a central Src homology
2 (SH2) domain flanked by two Src homology 3 (SH3) domains
(1–4). The SH2 domain binds specific phospho–tyrosyl residues
present on signaling proteins such as growth factor receptors,
insulin receptor substrate (IRS) proteins, and the hematopoietic
specific adaptor protein linker for activation of T cells (LAT) (4–
6). The SH3 domains of GRB2 bind proline-containing sequences
on intracellular ligands that drive further downstream signaling.
GRB2-mediated complexes regulate cell cycle progression, motil-
ity, angiogenesis, and differentiation of nearly all cell types (3, 7, 8).
Due to its role in propagating signaling pathways downstream of
numerous receptors, dysregulated GRB2-mediated signaling com-
plexes has been linked to oncogenesis, autoimmunity, diabetes, and
cardiovascular disease (3, 7, 8).
One physiological system dependent on GRB2 function is the
activation of CD4+T cells by the T cell receptor (TCR). Ligation of
the TCR by peptide antigen bound major histocompatibility com-
plexes (pMHC) on antigen presenting cells is the primary signal
required for T cell activation, differentiation, and proliferation (9,
10). Within seconds after TCR ligation, multiple kinases are acti-
vated that facilitate the phosphorylation of the adaptor protein
LAT (4, 11, 12). GRB2 and its homologs directly bind phospho-
rylated tyrosines at LAT, while simultaneously recruiting several
proline rich ligands to this complex. The SH3 domain ligands
for GRB2 include the E3 ubiquitin ligase CBL and the guanine
nucleotide exchange factor SOS1, which modulates the activa-
tion of the MAP kinases ERK1 and ERK2 (12, 13). In addition,
TCR-induced cytoskeletal arrangement and phosphatidylinositide
3-kinases (PI3K) activation is mediated through the localization
of GADS and its SH3 domain ligand, SLP-76, to the LAT complex
(9, 12, 14). Finally, LAT phosphorylation is critical for the recruit-
ment and activation of phospholipase-γ1 (PLC-γ1), which directly
modulates calcium influx and the activation of PKC isoforms (15).
In addition to its ability to recruit effector proteins, GRB2 may
also regulate the formation of large, megadalton sized LAT clusters.
All three GRB2 binding sites on LAT are required for the forma-
tion of LAT signaling clusters, and reduced dimerization of GRB2
via the overexpression of mutant SH3 domain ligands inhibits the
formation of LAT clusters (4, 12, 15, 16). However, the LAT muta-
tions and overexpression of SH3 domain ligands will also inhibit
the function of GRAP and GADS. In fact, the dimerization of
SLP-76 by its SH2 domain ligand ADAP has been suggested to
facilitate the clustering of SLP-76 and LAT. Thus, whether GRB2
alone or the combined function of GRB2, GRAP, and/or GADS
is critical for the formation of LAT clusters has not been directly
demonstrated. In addition, it is unknown if LAT phosphorylation
alone is sufficient for PLC-γ1 activation or if the formation of
LAT microclusters is required for the recruitment of PLC-γ1 to
the LAT complex. Thus, GRB2 may have both a signaling role, by
recruiting ligands to the LAT complex, and a structural role in
driving clustering of LAT, but the relative contribution of these
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events to function downstream of the TCR or other receptors is
unknown.
Although GRB2 clearly regulates TCR-mediated signaling, its
exact function downstream of this receptor is unknown. Recent
studies utilizing GRB2 conditional knockout (KO) or haplo-
deficiency in murine thymocytes demonstrated reduced proximal
signaling and normal ERK1/ERK2 activation (17, 18). However,
due to developmental issues, cells from these mice may have sig-
naling defects arising from impaired development and not the
role of these proteins in mature T cells. Also, human T cells with
reduced GRB2 expression have normal TCR-induced ERK1/ERK2
activation but no other functions have been assessed in these cells
(19). Thus, the full functions of GRB2 in mediating the different
signaling pathways in mature human T cells are unclear.
In this study, we have developed effective recombinant microR-
NAs that suppress the expression of GRB2. We observed that
GRB2 negatively controls early TCR signaling complexes. We also
demonstrate for the first time that GRB2 alone regulates the for-
mation of LAT microclusters, which drives PLC-γ1 recruitment to
LAT, calcium influx, and cytokine release in mature human T cells.
We have identified novel roles for GRB2 in mediating LAT signal-
ing complexes and subsequent downstream signaling in mature
human CD4+ T cells. Our studies also provide novel insight into
how the ability of GRB2 to control effector protein recruitment
and the formation of large signaling clusters is critical for the
induction of PLC-γ1 and calcium signaling downstream of other
receptors and adaptor proteins.
MATERIALS AND METHODS
ISOLATION AND GROWTH OF HUMAN CD4+ PERIPHERAL BLOOD
T CELLS
Peripheral blood mononuclear cells (PBMC) were first isolated
from whole blood of healthy donors using leukocyte reduction sys-
tem (LRS) cones as previously described (20). The blood donors
consented for blood donation at the DeGowin Blood Center at the
University of Iowa and to allow blood cells not used for trans-
fusion to be used for research at the University of Iowa. The
consent process and consent documents for these donors have
been approved by the IRB for the University of Iowa. Because all
cells used in these studies were obtained from normally discarded
products, the donors approved for the use of their cells in research
projects and the donors were completely de-identified; these stud-
ies were exempt from further IRB approval. Primary human CD4+
T cells were negatively selected using CD4+ T cell isolation kit II
(Miltenyi Biotec), resulting in>95% purity. Isolated CD4+T cells
were then activated with anti-CD3 (OKT3, BioLegend) and anti-
CD28 (CD28.2, BioLegend) crosslinked to magnetic Dyna beads
(Invitrogen) in the presence of 100 U/mL IL-2. Cells were cul-
tured for 3 days at 37°C and 5% CO2 in complete RPMI 1640
(RPMI media supplemented with 10% FBS, 50 U/mL penicillin,
50µg/mL streptomycin, and 2 mM l-glutamine) (Gibco). Prior
to human primary CD4+ T cell stimulation, cells were rested for
1 day in complete RPMI without magnetic beads or IL-2.
GROWTH AND STIMULATION OF HuT78 T CELL LINES
HuT78 CD4+ T cell lines were cultured at 37°C and 5%
CO2 in complete IMDM media (IMDM media supplemented
with 20% FBS, 50 U/mL penicillin, 50µg/mL streptomycin, and
2 mM l-glutamine) (Gibco). Cell lines transduced with retro or
lentiviruses containing GRB2 or luciferase (LUC) micro/shRNAs
and add-back GRB2 proteins were kept in selection with 2µg/mL
puromycin (CAS 58-58-2, Santa Cruz). Cell lines were grown
to a concentration of 2–5× 105 cells/mL prior to stimulations,
and then washed in un-supplemented RPMI 1640 (Gibco). They
were then resuspended in un-supplemented RPMI 1640 at 5× 107
cells/mL and incubated for 10 min at 37°C. The cells were stim-
ulated with soluble 2µg/mL anti-CD3 (OKT3, BioLegend) for
various time points and then lysed with the addition of four-
fold excess of hot 2X lysis buffer (20 mM Tris pH 8.0, 2 mM
EDTA, 2 mM Na3VO4, 20 mM DTT, 2% SDS, and 20% glycerol).
Lysates were then heated to 95°C for 4 min and sonicated to reduce
viscosity.
VECTORS AND microRNA/shRNA DESIGN
Vectors
Murine stem cell virus (MSCV)-LTRmiR30-PIG (LMP) retrovi-
ral expression vector and VSV-G were a kind gift from Dr. Bruce
Hostager. Lentiviral pLK4 vectors were donated by Dr. Stephen
Bunnell. pLKO.1 lentiviruses were obtained from Addgene (plas-
mid 8453) (21). Packaging plasmids pCL-Eco and Pax2 were
obtained from Drs. John Colgan and Dawn Quelle, respectively.
MicroRNA/shRNA targeting sequences against human GRB2
(NM_002086.4) were developed, utilizing a siRNA/shRNA based
algorithm formulated by Dr. Sachidanandam and coworkers
(http://katahdin.cshl.edu). The following sequences produced
>90% suppression and was selected as the primary hairpin
for targeting GRB2 in human T cells in this study (GRB2-
7 sense: 5′ AGCAGAAGAAATGCTTAGCAAA 3′, anti-sense: 5′
TTTGCTAAGCATTTCTTCTGCC 3′). The following sequence
produced >80% suppression and was selected as an alternative
GRB2 microRNA (GRB2-10 sense: 5′ CCGGCTTCATTCCCAA
GAACTA 3′, anti-sense: 5′ TAGTTCTTGGGAATGAAGCCGT′).
Hairpin delivery into HuT78 and primary human CD4+ T cells
HuT78 T cells were transduced with LMP retroviruses carrying
microRNAs with the exception of knockdown/add-back exper-
iments where lentiviruses carrying shRNAs were utilized. This
is due to the inefficiency of lentiviral hU6 promotor in dri-
ving microRNA-induced suppression. Next, because retroviral
LMP vectors carrying microRNAs are substantially less efficient
at infecting human primary CD4+ T cells, YFP-positive pLK4
lentiviral vectors carrying shRNAs were used for their trans-
duction. Sequences from pLKO.1 vectors containing the U6
promoter driving GRB2 or LUC shRNAs were amplified and
cloned into pLK4 lentiviral vectors using the following primers (F
hU6-SpeI: 5′ CAACCAACTAGTGAGGGCCTATTTCCCATGATT
CCTTCATATTTGC 3′, RGRB2-PvuI: 5′ TGGTTGCGATCGAA
AAAAGGCAGAAGAAATGCTTAGCAAATACATCTG 3′, RLUC-
PvuI: 5′ TGGTTGCGATCGAAAAAATGGCTCCCGCTGAATTG
GAATCTACATCT 3′).
shRNA-resistant GRB2 – wild-type and mutant add-back
To generate a wild-type GRB2 that is resistant to shRNA mediated
knockdown, GRB2 cDNA was mutated using primers containing
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shRNA-sense bases to produce wild-type GRB2 with a different
nucleotide sequence, but with an identical amino acid sequence.
The following primers were used:
Wild-type GRB2→Wild-type shRNA-Resistant GRB2 (F: 5′
GGCAAAATCCCCAGAGCCAAGGCGGAGGAGATGCTGAGTA
AGCAGCGGCACGATGGGGCC 3′, R: 5′ GGCCCCATCGTGC
CGCTGCTTACTCAGCATCTCCTCCGCCTTGGCTCTGGGGA
TTTTGCC 3′).
KVLN→AAAA mutation primer (F: 5′ TTCAAAAGGGGGGA
CATCCTCGCGGCTGCGGCCGAAGAATGTGATCAGAAC 3′, R:
5′ GTTCTGATCACATTCTTCGGCCGCAGCCGCGAGGATGTC
CCCCCTTTTGAA 3′).
Wild-type or KVLN shRNA-resistant GRB2 constructs were
then amplified and cloned into pLK4 vectors containing U6-GRB2
shRNA from above using the following primers (F-GRB2cDNA-
AgeI: 5′ CAGAATACCGGTCGCCACCATGGAAGCCATCGCC
AAATA 3′, R-GRB2cDNA-Not I: 5′ CAGAATGCGGCCGCAA
GGTATTAGACGTTCCGGTTCACG 3′).
293T CALCIUM PHOSPHATE TRANSFECTIONS AND VIRAL PRODUCTION
To produce pseudo-typed retro and lentiviral particles, the
microRNA/shRNA containing vectors (LMP, pLK4) were trans-
fected into 293T cells along with VSV-G envelope and packaging
vectors pCL-Eco and Pax2 for LMP and pLK4, respectively. About
18–24 h prior to infection, 3× 106 293T cells were seeded in 10 cm
culture dishes at 37°C and 5% CO2 in complete DMEM media
(DMEM media supplemented with 10% FBS, 50 U/mL penicillin,
50µg/mL streptomycin, 1X MEM NEAA, and 2 mM l-glutamine)
(Gibco). On the day of transfection, the media was replaced with
5 mL of fresh complete DMEM.
293T cells were transfected utilizing calcium phosphate
method. Briefly, plasmids (LMP or pLK4 15µg, pCL-Eco or
Pax2 10µg, VSV-G 7.5µg) were mixed together in 0.5 mL of
1X HBS buffer (Hepes free acid 21 mM, NaCl 137 mM, D+
Glucose monohydrate 5 mM, KCl 50 mM, Na2HPO4 0.35 mM,
pH 7.5). Next, 30µL of 2.5M CaCl2 was added drop-wise
to the HBS-DNA solution, mixed immediately, and incubated
for 30 min at room temperature. The HBS-DNA-CaCl2 mix
was then added drop-wise around the plate of 293T cells and
then incubated for 16–18 h. Transfection media was replaced
with fresh media, and viral containing supernatant was sub-
sequently harvested, and filtered through 0.45µm Durapore
Millex (Millipore) filters every 24 h for 2 days. Viral supernatants
were divided into round-bottom polycarbonate high-speed tubes
(Nalgene-Oak ridge). The tubes were centrifuged at 4°C for 1.5 h,
48,000× g in Sorvall RC6-Plus centrifuge (SS-34 Rotor). Viral pel-
lets were resuspended in complete RPMI media for subsequent
transductions.
TRANSDUCTION OF HUMAN T CELL LINES AND PRIMARY CD4+
T CELLS
For HuT78 T cell transductions, 5× 105 cells were incubated in
1–1.5 mL of concentrated viral supernatant in 25 cm2 flasks in the
presence of 8µg/mL Hexadimethrine bromide (Sigma Aldrich)
with periodical mixing. After 48 h,HuT78 T cells were resuspended
in fresh complete IMDM with 0.5µg/mL of puromycin and cells
were allowed to expand. Puromycin was then increased gradually
to 2µg/mL after initial cell expansion.
For primary human CD4+ T cell transductions, purified cells
were activated for 1 day as above, and then 10–20× 106 cells were
incubated in 1–1.5 mL of concentrated viral supernatant in 25 cm2
flasks in the presence of 8µg/mL Hexadimethrine bromide (Sigma
Aldrich) with periodical mixing. IL-2 along with beads containing
anti-CD3 and anti-CD28 were left during the transduction. About
1.5 mL of complete RPMI media, Hexadimethrine bromide, and
IL-2 were added to the cells every 24 h. After 72–96 h, cells were
resuspended in fresh complete RPMI without the beads or IL-
2. Due to the short lifetime of primary CD4+, YFP+ cells were
instead sorted using Becton Dickinson Aria II (Flow Cytometry
Facility, University of Iowa) to obtain a population (>98%) of
cells expressing GRB2 or LUC shRNA.
CYTOKINE DETECTION AND RT-PCR
Cells were washed in complete RPMI 1640, and then resuspended
at 2–5× 105 cells/mL. Cells were stimulated by adding 0.5 mL of
cell suspension to 24 well plates coated with various concentra-
tions of anti-CD3 for 24 h, or with 200 nM phorbol 12-myristate
13-acetate (PMA), and 1µM ionomycin for 4.5 h. IL-2 and IFN-γ
protein concentrations in the culture supernatants were measured
using standard TMB ELISA utilizing a spectrophotometric plate
reader with a reading absorbance at 450 nm. For RT-PCR, RNA
was extracted from stimulated cells using Qiagen’s Rneasy RNA
extraction kit per manufacturer’s protocol. The RT-PCR reaction
was run using SuperScript III One-Step RT-PCR (Invitrogen).
PCR primers were designed and obtained using IDT’s primer
quest (IL-2 F: 5′ CAGTGCACCTACTTCAAGTTCTA 3′, IL-2 R:
CCTCCAGAGGTTTGAGTTCTTC, IFN-γ F: GTGGAGACCAT-
CAAGGAAGAC, IFN-γ R: CAGGCAGGACAACCATTACT). The
reaction was run for 29 cycles and quantified using ImageStudio
Lite (Licor).
IMMUNOBLOTTING
Protein containing samples (equivalent of 5× 106 cells) were
loaded onto a 4–15% precast Criterion polyacrylamide gel (Bio-
rad). The separated proteins were transferred onto PVDF mem-
branes (Millipore), and then blocked for 1 h at room temperature
in a 1:1 1XPBS:SEA Block buffer (Thermo Scientific). The PVDF
membranes were then incubated with primary antibodies against
GRB2 (clone 23, Santa Cruz Biotechnology), LAT pY226 (clone
J96-1238.58.93, BD Pharmingen), LAT pY132 (Genetex), SLP-
76 pY128 (clone J141-668.36.58, BD Pharmingen), ERK1/ERK2
pY187/pT185 (Invitrogen), p38 pT180/pY182 (Cell Signaling),
JNK pT183/pY195 (Cell Signaling), Akt pS473 (clone-14-6, Invit-
rogen), Src pY416 (Cell Signaling), pY783 PLC-γ1 (Cell signal-
ing), PLC-γ1 (Cell Signaling), lymphocyte-specific protein tyro-
sine kinase (LCK) (Cell Signaling), pY (4G10, Millipore), Gsk3αβ
pS21/9 (Cell Signaling), actin (clone C4, Millipore), or GAPDH
(Meridian Life Sciences). Secondary antibodies conjugated to
IRDye 800CW or IRDye 680 were diluted in SEA Block and incu-
bated with the PVDF membranes for 30 min at room temperature.
The membranes were then visualized using the Licor Odyssey
Infrared detector.
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IMMUNOPRECIPITATIONS
10× 106 HuT78 T cells were washed in un-supplemented RPMI
and stimulated as above. The cells were then lysed using 800µL of
immunoprecipitation buffer (25 mM Tris pH 8.0, 150 mM NaCl,
1% Brij-97, 0.5% n-Octyl-β-d-glucopyranoside, 5 mM EDTA,
1 mM Na3VO4, complete protease inhibitor tablets). The cellu-
lar lysates were incubated on ice for 30 min and then centrifuged
(13000 rpm, 10 min). The supernatants were pre-cleared by rotat-
ing for 30 min with protein A/G plus agarose (Santa Cruz Biotech),
centrifuged, and the pre-cleared supernatants were incubated with
protein A/G plus agarose with or without immunoprecipitation
antibody overnight at 4°C. The beads were washed three times by
centrifugation (5000 rpm, 2 min) in immunoprecipitation wash-
ing buffer (25 mM Tris pH 8.0, 150 mM NaCl, 5 mM EDTA, com-
plete protease inhibitor tablets). The immunoprecipitated proteins
were eluted by incubating with 2X lysis buffer at 95°C for 4 min.
IMMUNOBLOT ANALYSIS
Densitometric analysis of protein bands was determined using
Odyssey’s v3.0 software. Normalization of phospho specific pro-
teins to pan forms may give misleading results due to the inability
of pan antibodies to detect phosphorylated forms and steric hin-
drance that can occur when two antibodies bind to the same small
protein. Thus, phosphorylated or total forms of proteins were nor-
malized to actin as previously described (20, 22). The following
formula was utilized for normalization and quantification of the
immunoblots, cytokine release, and RT-PCR:
1. Normalized data point to actin intensities (NP)= raw band
intensity÷ raw actin intensity.
2. Percent of maximum of LUC stimulation (as indicated)= (NP
time point-NP 0 time point of control LUC)÷ (NP max time
point of control LUC-NP 0 time point of control LUC).
FLOW CYTOMETRY
1× 106 cells were washed in FACS buffer (PBS, 10% FBS, and
0.05% sodium azide), and then resuspended in FACS buffer to a
concentration of 1× 106 cells/mL. The mean fluorescence inten-
sity (MFI) of each sample was obtained using Accuri C6 flow
cytometer.
CALCIUM INFLUX
1× 106 HuT78 T cells were washed and resuspended in 1 mL
RPMI 1640 without phenol-red (Gibco). About 5µL of 1 mM
Fluo-4 AM (Life Technologies), and 10µL of 250 mM probenecid
(Life Technologies) were added to the samples, and then incu-
bated at 37°C and 5% CO2 for 45 min. Cells were washed twice
in RPMI without phenol-red and then resuspended at 1× 106
cells/mL in RPMI-probenecid, and left on ice for 15 min. Cells
were incubated at 37°C 5 min prior to stimulations. Cells were run
un-stimulated for 35 s, and then stimulated with 5µg/mL anti-
CD3 for 6–7 min. The MFI of each sample was obtained using
Accuri C6 flow cytometer. Statistical analysis per stimulation was
calculated based on 10 live cell events per tenth of a second (i.e.,
100 cells/s). Groups were graphed based on un-stimulated fold
increase.
For assays requiring calcium free media, cells were prepared as
above. After incubation in RPMI on ice for 15 min, cells were
washed in warm HBSS without phenol-red (Gibco), with or
without calcium. Cells were then stimulated with anti-CD3 for
6 min.
TOTAL INTERNAL REFLECTION FLUORESCENCE MICROSCOPE
Cell membrane imaging was performed using Leica AM TIRF MC
imaging system as previously reported (20, 23). Briefly, 2.5× 105
HuT78 or primary CD4+ T cells were seeded onto glass chamber
slides (LabTek II, Nalgene Nunc International) that were coated
with 10µg/mL anti-CD3. Cells were activated for the indicated
times and then fixed with 3% paraformaldehyde-PBS solution for
30 min. The cells were then permeabilized with 0.25% TritonX-100
in PBS for 5 min and washed in PBS, blocked with SEA block, and
stained overnight with the indicated antibodies. Cells were then
incubated with secondary antibodies (Alexa 488 goat anti-mouse
IgG1-BioLegend, Alexa 568 goat anti-mouse IgG1-Invitrogen) for
2 h. Images were acquired using Leica AF software and processed
using Adobe Photoshop and ImageJ software. All images were
captured using 100X oil objective.
Analysis of LAT cluster intensities was performed by drawing
one line per cell through original images and performing“Plot Pro-
file” analysis on ImageJ. At least 20 cells from three independent
experiments (greater than 60 cells/group) were analyzed, com-
piled, and graphed as pixel-intensity plots. For 3D cluster analysis,
ImageJ’s “Maximum Entropy Threshold” segmentation analysis
was performed on 8-bit grayscale images, and graphed utilizing
ImageJ’s “Interactive 3D Surface Plot”.
STATISTICAL ANALYSIS
Analysis of immunoblots, RT-PCR, and cytokine assays were
performed in Graphpad prism software using two-tailed t -test
assuming equal variance. Analysis of calcium influx data was per-
formed using Microsoft Excel using a two-tailed t -test. Levels of
significance p< 0.05 and p< 0.005 are presented as ∗ and ∗∗,
respectively.
RESULTS
REDUCED EXPRESSION OF GRB2 THROUGH microRNA AND
shRNA-MEDIATED SUPPRESSION
We cloned potential microRNA targeting sequences for GRB2 into
a modified form of the human miR30 microRNA in viral packag-
ing vectors that have a gene for YFP to identify transduced cells.
The most efficacious sequence produced >90% suppression of
GRB2 expression in both CD4+ HuT78 T cells and YFP+ pri-
mary human CD4+ T cells from normal donors (Figure 1A and
Figure S1A in Supplementary Material). Interestingly, the hU6
promoter in the lentiviral constructs was only efficient if the target-
ing sequence was inserted as a shRNA instead of microRNA (data
not shown). The structural difference between the microRNA
and the shRNA is that the microRNA contains flanking miR30
sequences while in the shRNA these sequences were removed,
but the GRB2 targeting sequence is identical in both these sup-
pressive RNAs. However, there was no large difference in the
effectiveness of each type of targeting sequence, since our stud-
ies in HuT78 T cell line performed utilizing both miR30 and
shRNA constructs had identical results (data not shown). To con-
firm that there were no off target effects in signaling pathways
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FIGURE 1 | GRB2 deficient human CD4+T cells exhibit substantial
reduction inTCR-induced cytokines release. (A) Top: expression of
GRB2 and actin in HuT78 and human primary CD4+YFP+T cells
carrying GRB2 or luciferase (LUC) microRNAs and shRNAs, respectively.
Bottom: Quantification of GRB2 suppression in primary human CD4+
and HuT78 T cells. (B,C) IL-2 and IFN-γ production in GRB2 deficient and
LUC HuT78 T cells or YFP+ primary human CD4+T cells stimulated with
plate bound anti-CD3 for 24 h. The mean normalized value±SEM of
seven independent experiments (HuT78 T cells) or three different donors
(primary CD4+T cells) is shown.
downstream of the TCR, the expression of various signaling pro-
teins was examined. Surface TCR levels between GRB2 and control
cells transduced with a microRNA targeting firefly LUC displayed
similar expression (Figure S1B in Supplementary Material). In
addition, there was no difference in total protein expression for
LAT, PLC-γ1, SOS1, LCK, GADS, AKT, SLP-76, and PI3K between
www.frontiersin.org March 2015 | Volume 6 | Article 141 | 5
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Bilal and Houtman GRB2 regulates TCR-induced cytokine production
GRB2 deficient and LUC cells (Figures S1C–E in Supplementary
Material).
GRB2 IS REQUIRED FOR TCR-INDUCED CYTOKINE PRODUCTION IN
HUMAN CD4+ T CELLS
The role of GRB2 in controlling downstream T cell functions
has not been tested extensively. To address this issue, we exam-
ined the ability of GRB2 deficient T cells to secrete the crucial
immunomodulatory cytokines, IL-2, and IFN-γ. Both IL-2 and
IFN-γ production were significantly reduced in GRB2 deficient
HuT78 T cells compared to control cells (Figures 1B,C). Similarly,
GRB2 deficient primary human CD4+ T cells exhibited a signifi-
cant reduction of IL-2 release, but had comparable IFN-γ secretion
(Figures 1B,C). The contrasting effects on IFN-γ release may be
due to the strong priming received via CD3 and CD28 prior to
GRB2 knockdown. HuT78 T cells carrying an alternative GRB2
microRNA also displayed impaired IL-2 and IFN-γ production
(Figure 2A), showing that the suppression of GRB2 expression,
and not specific off-target effects, are driving reduced cytokine
release. These results were confirmed at the mRNA levels as tran-
scripts of IL-2 and IFN-γ were diminished in GRB2 deficient cells
relative to control HuT78 T cells (Figure 2B). Interestingly, basal
levels of IFN-γ mRNA were markedly reduced in un-activated
GRB2 deficient cells compared to control (Figure 2B).
To assess if the impairment in cytokine production occurred
due to defects at the TCR or LAT complexes, GRB2 deficient cells
were treated with PMA and ionomycin (IO), a strong T cell activa-
tor that bypasses the TCR and LAT complexes. Interestingly, upon
PMA-IO stimulation, GRB2 deficient cells were able to secrete
similar levels of IL-2 and a modest amount of IFN-γ compared
to control LUC HuT78 T cells (Figure 2C). Overall, these results
indicate a requirement for GRB2 in driving cytokine production
in human CD4+ T cells, and that the defects in TCR-induced
cytokine production in GRB2 deficient cells are due to alterations
in proximal signaling at the TCR and LAT complexes.
GRB2 DEFICIENT CELLS DISPLAY ENHANCED PROXIMAL TCR
SIGNALING
The previous data shows that GRB2 is required for optimal
cytokine production in human CD4+ T cells. To determine how
GRB2 controls signaling pathways downstream of the TCR, we
examined the effects of GRB2 deficiency on TCR-mediated sig-
naling. TCR ligation induces the activation and/or recruitment of
the Src family kinase LCK, which then phosphorylates proteins at
the TCR complex including ZAP-70 and the TCR ζ chain (10).
Enzymatically active ZAP-70 phosphorylates and activates essen-
tial signaling proteins at the TCR/LAT complexes including LAT
and SLP-76 (10, 24). In contrast to our expectations based on
the cytokine release data, GRB2 deficient HuT78 T cells exhib-
ited augmented tyrosine phosphorylation in the activation site
of LCK (Figure 3A). As expected by the enhanced LCK activa-
tion, phosphorylation levels of ZAP-70 and TCR ζ chain were also
increased in the absence of GRB2 (Figure 3A and Figure S2A in
Supplementary Material). Additionally, SLP-76 phosphorylation
at Y128 was enhanced in GRB2 deficient cells (Figure 3B). We also
observed increased phosphorylation of AKT and GSKαβ, both of
which are dependent on the recruitment of PI3K by SLP-76 to
the LAT signaling complex (Figure 3B) (14). These findings are
supported by the observation that GRB2 deficient cells, HuT78 T
cells, have enhanced total TCR-induced tyrosine phosphorylation
of the above mentioned proximal proteins (Figure S2A in Supple-
mentary Material). These results indicate that GRB2 functions as
a negative regulator at the TCR complex.
LAT PHOSPHORYLATION ON THE GRB2 BINDING SITE (Y226) IS NOT
IMPAIRED IN THE ABSENCE OF GRB2
Previous studies have demonstrated that GRB2 family of adaptors
bind phosphorylated LAT Y171, Y191, and Y226, thereby driving
essential TCR-mediated signaling (12, 15, 25). It is possible that
GRB2 binding protects these sites on LAT from being dephospho-
rylated by specific phosphatases. However, the increased function
of ZAP-70, the kinase for LAT, could result in enhanced LAT
phosphorylation. To dissect whether GRB2 deficiency alters LAT
phosphorylation on GRB2 binding site after TCR stimulation,
GRB2 and LUC HuT78 T cells were stimulated and probed for total
phosphorylated LAT and Y226. Compared to the GRB2 homolog,
GADS, pY226 on LAT has substantially more affinity for GRB2
binding in vivo (25). Additionally, monoclonal antibodies against
pY226 are more specific and have no variation between batches
compared to polyclonal pY191 antibodies (data not shown). Inter-
estingly, we found that both total and LAT Y226 phosphorylation
are not affected by the absence of GRB2 (Figure 3C and Figure
S2A in Supplementary Material). These data suggest that GRB2 is
not required for phosphorylation of LAT at Y226.
GRB2 IS REQUIRED FOR OPTIMAL TCR-INDUCED MAP KINASE
ACTIVATION
GRB2 is thought to facilitate the activation of ERK1/ERK2 in
T cells by linking SOS1 to Ras at the cellular membrane (26).
However, recent studies have challenged the requirement of the
GRB2-SOS1 complex in driving full activation of TCR-induced
ERK1/ERK2 (18, 19). The activation of p38 and JNK is mediated
through small GTP binding proteins RAC-1, CDC42, and RHO,
but the mechanisms for the activation of p38 and JNK upon TCR
stimulation are not well characterized (27–29). Similar to previ-
ous studies, we observed that phosphorylation of ERK1/ERK2 was
moderately reduced, but not completely suppressed, 10–15 min
after activation when GRB2 expression is suppressed in HuT78
T cells (Figure 4A). The activation of p38 and JNK were sub-
stantially, but not completely, reduced in the absence of GRB2
(Figure 4B). Our results corroborate earlier findings indicating
that GRB2 is needed for optimal activation of ERK1/ERK2 (17–
19), and demonstrate that GRB2 is also essential for optimal
TCR-induced p38 and JNK activation.
GRB2 IS ESSENTIAL FOR THE ACTIVATION AND RECRUITMENT OF
PLC-γ1 TO THE LAT SIGNALOSOME
After TCR ligation, LAT is rapidly phosphorylated, thereby allow-
ing the recruitment of PLC-γ1 to the cellular membrane (12, 13,
23). PLC-γ1 is then activated through phosphorylation on Y783,
resulting in enhanced calcium influx needed for cytokine pro-
duction (10, 15). Because PLC-γ1 is recruited to LAT and the
role it plays in cytokine production, we assessed if GRB2 deficient
cells had impaired calcium influx. Interestingly, HuT78 T cells
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FIGURE 2 | ImpairedTCR-induced transcriptional activity and PMA-IO
mediated cytokine release in GRB2 deficient HuT78T cells. (A) HuT78
T cells carrying an alternative GRB2 (GRB2-10) or LUC microRNA were
stimulated with 5µg/mL plate-bound anti-CD3 for 24 h and the
supernatants were probed for IL-2 and IFN-γ via ELISA. The mean
normalized value±SEM from three independent experiments is shown.
(B) IL-2 and IFN-γ mRNA expression in HuT78 T cells carrying primary
GRB2 or LUC microRNAs stimulated with 5µg/mL anti-CD3 for 24 h. The
mean normalized value±SEM from three independent experiments is
shown. (C) IL-2 and IFN-γ protein release in HuT78 T cells stimulated with
PMA-IO for 4.5 h. The mean normalized value±SEM from three
independent experiments is shown.
with reduced GRB2 expression had marked reduction in the peak
levels of calcium influx and time to return to baseline calcium lev-
els (Figure 5A). Stimulating GRB2 deficient cells in calcium-free
media resulted in reduced release of internal calcium stores relative
to control cells (Figure S2B in Supplementary Material), suggesting
a defect in PLC-γ1 function.
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FIGURE 3 | GRB2 deficient cells display enhanced proximalTCR
signaling. The phosphorylation of proteins in GRB2 deficient or control
HuT78 T cells stimulated with 2µg/mL soluble anti-CD3 was detected by
immunoblotting using antibodies against (A) pY416 Src (LCK) n=6, pY142
CD3ζ chain n=5. (B) pY128 SLP-76 n=6, pSer473 AKT n=7, pSer21/9
GSKαβ n= 3. (C) pY226 LAT n=5. The levels of phosphorylation were
normalized to actin expression and graphed as mean percentage
phosphorylation of LUC±SEM for each time point.
We next examined if the phosphorylation and recruitment of
PLC-γ1 to LAT was diminished in the absence of GRB2. GRB2
deficient cells had reduced phosphorylation of Y783 on PLC-γ1
compared to control HuT78 T cells (Figure 5B). We next hypoth-
esized if the reduction of PLC-γ1 phosphorylation was due to
impaired phosphorylation of LAT Y132, the PLC-γ1 binding site
on LAT. In contrast to LAT Y226, but similar to Y783 on PLC-γ1,
phosphorylation of LAT Y132 was impaired in the absence of
GRB2 (Figures 3C and 5B,C). Next, because the phosphorylation
levels of Y783 and Y132 on PLC-γ1 and LAT, respectively, did not
correlate with the marked reduction of calcium mobilization, we
asked if recruitment of PLC-γ1 to LAT was impaired in the absence
of GRB2. Corresponding with the attenuated calcium flux, the
interaction between PLC-γ1 and LAT was undetectable in GRB2
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FIGURE 4 | Activity of MAP kinases, ERK1/ERK2, p38, and JNK is
reduced in the absence of GRB2. The phosphorylation of proteins in
GRB2 deficient or control HuT78 T cells stimulated with 2µg/mL soluble
anti-CD3 was detected by immunoblotting using antibodies against
(A) pY187/pT185 ERK1/ERK2 n=5, pT180/pY182 p38 n=5,
(B) pT183/pY195 JNK n=5. The levels of phosphorylation were normalized
to actin expression and graphed as mean percentage phosphorylation of
LUC±SEM for each time point.
deficient T cells after TCR stimulation (Figure 5D). Interestingly,
the latter occurred even as the total or Y226 LAT phosphory-
lation was similar or slightly increased in GRB2 deficient cells
(Figures 3C and 5D). These data indicate that phosphorylation of
LAT Y132 regulates the activation but not the stability of PLC-γ1
binding to the LAT complex. Overall, our results demonstrate that
GRB2 is required for the optimal activation and recruitment of
PLC-γ1 to the LAT complex and subsequent cytoplasmic calcium
mobilization.
GRB2 FACILITATES THE NUCLEATION OF LAT MICROCLUSTERS
Upon TCR activation, multiprotein complexes at LAT are concen-
trated into signaling microclusters. Disruption of LAT signaling
clusters through the mutation of LAT-oligomerizing ligand SOS1
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FIGURE 5 | GRB2 deficient cells have impairedTCR-induced calcium
influx and recruitment of PLC-γ1 to the LAT complex. (A) Calcium influx in
GRB2 deficient or control HuT78 T cells stimulated with 5µg/mL soluble
anti-CD3. The data is shown as fold increase of average cellular fluorescent
intensity over baseline average cellular fluorescent intensity±SEM of four
independent experiments. (B) The phosphorylation of PLC-γ1 in GRB2
deficient or control HuT78 T cells stimulated with 2µg/mL soluble anti-CD3
was detected by immunoblotting using antibodies against pY783. The levels
of phosphorylation of PLC-γ1 was normalized to actin expression and graphed
as mean percentage phosphorylation of LUC±SEM for each time point of
four independent experiments. (C) GRB2 deficient or control HuT78 T cells
were stimulated as in “(B)” and then the protein levels were detected using
antibodies against pY132 LAT and actin. The levels of phosphorylation of Y132
was normalized to actin expression and graphed as mean percentage
phosphorylation of LUC±SEM of four replicates. (D) PLC-γ1 was
immunoprecipitated from HuT78 T cells stimulated with 2µg/mL soluble
anti-CD3 for 2 min with anti-PLC-γ1 or no antibody control (2M) and the
phosphorylation or binding of specific proteins was assessed by
immunoblotting. Data shown is representative of four independent
experiments.
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attenuates TCR-induced calcium signaling (4, 16). Similarly, muta-
tion of LAT tyrosines responsible for GRB2, GRAP, and GADS
binding impairs LAT-induced signaling, including PLC-γ1 phos-
phorylation and calcium influx (4, 15). Because of these data, it was
hypothesized that GRB2 is required for LAT clustering by recruit-
ing SOS1 to LAT (4, 16). However, it is unclear if GRB2 alone is
required for the formation of LAT clusters or if other homologs,
such as GRAP, that can bind SOS1, may also have a role in LAT
oligomerization (30). Additionally, it is unclear what large scale
clustering of LAT does to facilitate downstream signaling from the
LAT complex.
To test if GRB2 is required for the formation of LAT microclus-
ters, we utilized high resolution total internal reflection fluores-
cence microscopy (TIRF). This method allows the visualization of
T cell plasma membrane with a depth of up to 150 nm, which
allows the imaging of LAT microclusters without background
noise from the cell body. To this end, HuT78 T cells expressing
GRB2 or control LUC shRNA were stimulated with anti-CD3
bound glass chambers and then probed with antibodies against
phosphorylated LAT Y226, which we previously found to be phos-
phorylated equally in GRB2 sufficient and deficient HuT78 T cells
(Figure 3C). A marked disruption of LAT oligomerization was
observed in GRB2 deficient HuT78 and primary human CD4+ T
cells compared to control cells (Figure 6A). Clustering algorithms
with 3D graphical analysis demonstrate dense LAT clusters in con-
trol cells when compared to GRB2 deficient primary CD4+ and
HuT78 T cells (Figure 6B). Additional quantification of LAT clus-
ter signal intensity in multiple cells revealed significant reduction
of the intensity of LAT clusters along the cell axis in GRB2 defi-
cient HuT78 T cells when compared to control cells (Figure 6C
and Figure S2C in Supplementary Material).
We next examined if the ability of GRB2 to bind SH3
domain ligands is needed for LAT clustering. To accomplish
this, we suppressed endogenous GRB2 and then re-expressed a
shRNA-resistant wild-type GRB2 or an N-terminal SH3 domain
(KVLN→AAAA) mutant of GRB2. The KVLN motif was iden-
tified due to its location around residues missing from the GRB2
crystal structure (residues 28–33) of the N-terminal SH3 domain
of GRB2 (31). This suggested that a KVLN→AAAA mutation
would inhibit the GRB2-SOS1 interaction. The shRNA-resistant
wild-type and KVLN mutant could be expressed in HuT78 T
cells where intrinsic GRB2 was substantially reduced (Figure 6D).
As assessed by GRB2 immunoprecipitations, both wild-type and
KVLN GRB2 interacted with phosphorylated LAT, but only wild-
type GRB2 was able to bind to SOS1 (Figure 7A). This demon-
strates that the KVLN mutant of GRB2 disrupts the interaction
with SH3, but not SH2 domain ligands. Interestingly, LAT micro-
clusters found in cells reconstituted with wild-type GRB2 were
consistently denser and more intense when compared to control
HuT78 T cells (Figures 6A–C). The latter is likely due to rela-
tive overexpression of GRB2 in reconstituted cells that leads to
enhanced LAT aggregation compared to LUC control cells. Recon-
stitution of GRB2 N-terminal KVLN mutant in GRB2 deficient
cells was unable to rescue the formation of LAT microclusters
(Figures 6A–C). These data demonstrate the importance of the
N-terminal SH3 domain of GRB2 in mediating LAT oligomeriza-
tion. We then examined if reconstitution of clustering by GRB2
variants rescued T cell functions suppressed in GRB2 deficient T
cells. GRB2 deficient cells reconstituted with wild-type GRB2 but
not the KVLN mutant were able to recover calcium mobilization
and cytokine production (Figures 7B,C) absent in GRB2 deficient
T cells. HuT78 T cells reconstituted with KVLN mutant GRB2 had
reduced PLC-γ1 phosphorylation when compared to cells contain-
ing wild-type GRB2 (Figure 7D). Overall, our results demonstrate
that the binding of GRB2 to SH3 domain ligands is critical for the
TCR-induced nucleation of large scale LAT microclusters, which
ultimately drive subsequent PLC-γ1 phosphorylation, calcium
influx, and cytokine production.
DISCUSSION
In the present study, we have potently silenced the expression of
GRB2 in mature primary human CD4+ T cells and the HuT78
CD4+ T cell line. Surprisingly, our data demonstrates that GRB2
deficiency substantially enhances LCK, CD3ζ chain, ZAP-70, and
SLP-76 phosphorylation (Figure 3 and Figure S2A in Supple-
mentary Material), suggesting GRB2 negatively regulates the first
signaling events at the TCR complex. Elucidating how GRB2 nega-
tively controls proximal TCR signals is a massive effort beyond the
scope of the present study. However, we hypothesize that GRB2
negatively controls TCR activation in two different manners. First,
dimeric GRB2 inhibits the activation of the FGF receptor (FGFR),
but upon tyrosine phosphorylation, dimerization is disrupted and
FGFR inhibition is released (6). GRB2 associates with CD3ζ chain
and ZAP-70 and has been localized by microscopy to the TCR com-
plex (32–34). We propose that GRB2 could dimerize and interact
with these molecules, thereby increasing the threshold of TCR acti-
vation. Second, GRB2 may recruit proline rich negative regulators
to the TCR complex. This process may occur independently or
through other mediators, such as the GRB2 binding protein SHC.
In fact, SHC has been found to be associated with GRB2, the CD3ζ
chain of the TCR, LCK, and ZAP-70 (32, 33, 35, 36). Thus, GRB2,
alone or via SHC, may recruit negative regulators such as CBL,
LYP, and FAK to interact with the TCR complex, thereby reduc-
ing CD3ζ, ZAP-70, or LCK activation (20, 37, 38). Collectively,
these results demonstrate that GRB2 plays an important role in
controlling the magnitude of early TCR signals.
In contrast to our studies, GRB2 deficient murine thymocytes
had reduced TCR-induced phosphorylation of LCK and ZAP-70
(18). The discrepancy may originate from issues with T cell devel-
opment or differences in signaling between murine thymocytes
and human mature T cells (39). Indeed, GRB2 KO CD4+ T cells
failed to up-regulate CD3 and down-modulate heat-stable antigen
(HSA) (18). Thus, a failure to arrange critical TCR molecules dur-
ing development likely leads to the diminished signaling deficiency
observed in GRB2 KO thymocytes. Interestingly, GRB2 KO B cells
display enhanced proximal signaling and calcium mobilization,
but these cells do not form germinal centers (40, 41). Overall, these
data suggest that GRB2 differentially controls signaling complexes
in diverse cell types depending on available ligands.
We also observed that GRB2 is not absolutely required for the
activation of ERK1/ERK2. This outcome was not surprising, as
recent work demonstrated that ERK1/ERK2 activation was similar
or even enhanced depending on the stimuli when both GRB2 and
SOS1 expression were moderately suppressed in primary human
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FIGURE 6 | GRB2 deficiency disrupts LAT microclusters. (A) HuT78 or
primary human CD4+YFP+T cells were stimulated for 5 min on anti-CD3
coated glass coverslips. LAT microclusters were visualized by
immunofluorescent TIRF microscopy utilizing pY226 LAT antibody. (B) HuT78
or primary human CD4+YFP+T cells were stimulated as in (A). For 3D
visualization of microclusters, single cells were analyzed and graphed using
ImageJ’s segmentation analysis and 3D interactive plot. (C) The average
intensities of clusters across the axis of T cells containing GRB2 shRNA
(n=65), LUC shRNA (n=60), wild-type GRB2 (n=60), KVLN (n=60) were
quantified using ImageJ’s “Plot Profile” function. (D) Top: schematic diagram
of GRB2 knockdown and shRNA-resistant protein reconstitution. Bottom: The
expression of GRB2 in HuT78 T cells transduced with lentiviral constructs
carrying LUC and GRB2 shRNA with or without re-expression of
shRNA-resistant GRB2 proteins.
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FIGURE 7 | Rescue ofT cell function after reconstitution of wild-type but not KVLN GRB2.
(Continued )
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FIGURE 7 | Continued
(A) Top: GRB2 was immunoprecipitated from HuT78 T cells expressing
wild-type or KVLN GRB2 stimulated for 2 min with 2µg/mL soluble
anti-CD3. The expression or phosphorylation of various proteins in the
immunoprecipitates and lysates were assessed by immunoblotting. The
data shown is a representative of three experiments. Bottom:
quantification of GRB2:SOS1 and GRB2:pYLAT binding from GRB2
immunoprecipitation. (B) Calcium influx in HuT78 T cells transduced with
lentiviral constructs carrying LUC and GRB2 shRNA with or without
re-expression of shRNA-resistant GRB2 proteins stimulated with 5µg/mL
soluble anti-CD3. The data is shown as fold increase of average cellular
fluorescent intensity over baseline average cellular fluorescent
intensity±SEM of four independent experiments. (C) IL-2 production in
HuT78 T cells transduced with GRB2 shRNA with or without re-expression
of shRNA-resistant GRB2 proteins stimulated with 5µg/mL plate-bound
anti-CD3 for 24 h. The mean normalized value±SEM from three
independent experiments is shown. (D) The phosphorylation of PLC-γ1 in
HuT78 T cell lines expressing wild-type or KVLN GRB2 stimulated for 2 min
soluble anti-CD3 was detected by immunoblotting using antibodies against
PLC-γ1 pY783. The levels of phosphorylation of PLC-γ1 was normalized to
actin expression and graphed as mean percentage phosphorylation of
LUC±SEM of three replicates.
T cells with synthetic siRNA (19). Likewise, GRB2 KO thymocytes
had similar activation of ERK1/ERK2 compared to wild-type (18).
In contrast and similar to murine thymocytes, p38 and JNK were
markedly reduced in GRB2 deficient HuT78 T cells. The inability
of GRB2 deficiency to inhibit ERK1/ERK2 activation can be linked
to multiple factors. First, RasGRP rather than SOS1 may drive
TCR-induced ERK1/ERK2 activation (19, 42, 43). Knockdown of
RasGRP but not SOS1/2 altered ERK1/ERK2 activation (19), but
both RasGRP and SOS1 are required for sustained ERK1/ERK2
activation in murine thymocytes and primary human CD4+ T
cells (16, 43). Activation of Ras by RasGRP through the PLC-
γ1/DAG pathways is possible in T cells (26). However, our data
suggest that this pathway is defective due to reduced PLC-γ1
signaling in the absence of GRB2. This suggests a second mech-
anism where a compensatory adaptor protein such as the GRB2
homolog GRAP may produce redundant TCR-induced signaling,
since GRAP can also bind to LAT and SOS1 (30).
Our data demonstrate that GRB2 facilitates the nucleation of
LAT microclusters in human T cells (Figure 8). Although it was
previously hypothesized that GRB2 is essential for inducing LAT
signaling clusters through the recruitment of SH3 domain ligands
such as SOS1, SOS2, and CBL, this concept has not been directly
demonstrated (4, 16). Since other SH3 domain containing proteins
such as GADS and GRAP can be dimerized by SH3 domain ligands
brought to the LAT complex, one cannot rule out the potential of
redundancy (30, 44). However, this does not appear to be the case,
since GRB2 deficiency disrupts LAT clusters. In addition, reconsti-
tuting GRB2 deficient cells with wild-type shRNA-resistant GRB2
rescues LAT clustering to a higher degree when compared to LUC
control cells. Moreover, a GRB2 with a mutation to the N terminal
SH3 domain that eliminates the interaction of GRB2 with SOS1
was incapable of rescuing LAT clusters in GRB2 deficient cells
(Figures 6A,B). Overall, our data conclusively show that GRB2 is
the key player in the formation of large TCR-induced LAT signaling
clusters.
A major unanswered question is what is the clustering of
LAT doing to drive TCR-mediated signaling. Interestingly, GRB2
deficient cells had reduced cytoplasmic calcium entry, PLC-γ1
activation, and stable binding of PLC-γ1 to phosphorylated LAT.
However, although GRB2 deficient cells had normal levels of LAT
Y226 phosphorylation, LAT Y132 had reduced levels of phos-
phorylation indicating differential regulation of LAT tyrosines by
GRB2. The reduction of phosphorylated LAT Y132 in the absence
of GRB2 could be a result of the instability of PLC-γ1 at the LAT
complex which could be important in shielding phosphorylated
Y132 from phosphatases compared to other tyrosines which are
bound by GADS or GRAP. Moreover, the disparate results between
normal total phosphorylated LAT and phosphorylated Y132 in the
absence of GRB2 are likely due to the stoichiometry of phospho-
rylation between tyrosine residues on LAT. Specifically, LAT Y132
could account for a low percentage of total LAT phosphorylation
relative to other sites, and therefore a reduction of 55% of the
phosphorylation of Y132 will not be evident in a total phospho-
tyrosine blot. Overall, these data and our results strongly suggest
the importance of GRB2-induced clustering in stabilizing PLC-
γ1 at the LAT-cell membrane junction. The levels of LAT Y132
phosphorylation matched closely with the reduction of PLC-γ1
phosphorylation on Y783 in the absence of GRB2 (Figures 5B,C).
These data indicate that Y132 on LAT is required for optimal
PLC-γ1 activation. However, the modest reduction of the levels
of pY132 on LAT and pY783 on PLC-γ1 in the absence of GRB2
do not explain the undetectable binding between PLC-γ1 and LAT
or the substantial impairment of calcium mobilization. Instead, we
propose that the binding of GRB2 to Y171, Y191, and Y226 leads
to LAT oligomerization that is critical for the stability of PLC-γ1
at the LAT complex. This is supported by previous studies demon-
strating that, in addition to PLC-γ1 binding phosphorylated Y132
on LAT, mutation of GRB2-binding tyrosines Y171, Y191, and
Y226 inhibited PLC-γ1 recruitment (15, 45).
Next, our results are in contrast to GRB2 haploid insufficiency
or complete KO thymocytes where calcium influx was similar
or slightly reduced, respectively (17, 18). However, recent GRB2
studies in murine platelets demonstrate that, after GPVI-induced
stimulation, GRB2 KO platelets had reduced LAT, SLP-76, and
PLC-γ2 phosphorylation and subsequent calcium influx (46). On
the other hand, GRB2 can function as a negative regulator of
calcium entry in B cells, as GRB2 KO B cells exhibit enhanced
proximal signaling and calcium influx (40, 41). Thus, the role of
GRB2 in mature human T cells is different relative to thymocytes, B
cells, or other hematopoietic cellular signaling pathways. However,
in mature human CD4+ T cells, the ability of GRB2 to facilitate
LAT clustering is critical for the activation and function of PLC-γ1.
Silencing of GRB2 substantially reduced both protein and tran-
script levels of IL-2 and IFN-γ in HuT78 T cells. Deficiency of
cytokine release was bypassed via PMA-IO stimulation, which
suggested a defect at the TCR/LAT complex. However, IL-2 was
only partially rescued when GRB2 deficient cells were stimulated
through TCR+PMA or IO alone (data not shown). This suggests
that the activation of MAP kinases, activated via PMA (47, 48),
and calcium influx are needed to fully rescue T cell function in the
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FIGURE 8 | GRB2-induced LAT oligomerization control the recruitment
and activation of effector signaling complexes. TCR activation induces the
phosphorylation of LAT molecules by TCR-associated proximal kinases. GRB2
recruits SOS1 and other proline rich ligands to the LAT complex by linking its
SH2 domain to the phospho-tyrosines at LAT. GRB2-SOS1 complexes create
a signaling framework by linking multiple LAT proteins, thereby forming LAT
signaling microclusters. The assembly of LAT clusters is critical for the
recruitment and stability of signaling molecules such as PLC-γ1 and
molecules required for MAP kinase activation. These events lead to essential
signal transduction required for T cell effector function.
absence of GRB2. Primary CD4+ T cells from normal human
donors also exhibited a significant reduction of TCR-induced
IL-2 release. However, we found that TCR-induced IFN-γ was
only slightly affected by the knockdown of GRB2 in pre-activated
primary CD4+ T cells.
Our results suggest that GRB2 controls TCR-induced IL-2 and
IFN-γ through different mechanisms. This idea is supported by
our observation that IL-2 was fully rescued while IFN-γ was
only partially rescued through PMA-IO stimulation in HuT78 T
cells. In addition, basal levels of IFN-γ mRNA in GRB2 deficient
cells were not detectable in un-stimulated cells compared to con-
trol cells, and only increased slightly after TCR stimulation. The
absence of basal IFN-γ mRNA in GRB2 deficient HuT78 T cells
indicates regulation of the IFN-γ promoter in T cells via tonic
signaling. Finally, GRB2 may differentially regulate cytokine pro-
duction in T cell lines derived from lymphomas, such as HuT78 T
cells, compared to primary T cells. On the basis of these observa-
tions, we conclude that GRB2 is required for IL-2 production in
T cells, but is only required for TCR-induced IFN-γ secretion in
certain T cell populations. Future studies will elucidate if GRB2 is
important for differential TCR signaling triggered in naïve versus
memory cells, which have distinct capacities to produce IL-2 and
IFN-γ (49–51).
In conclusion, our results show that GRB2 is critical for TCR-
induced LAT microclusters, calcium influx, and downstream sig-
naling events independent of its ability to negatively regulate
signaling at the TCR complex (Figure 8). Importantly, our data
suggests that GRB2 KO thymocytes fail to undergo both positive
and negative selection as a result of defective LAT-induced signal-
ing observed in GRB2 deficient mature human T cells (17, 18, 52).
Results from these studies may also provide further insight into
the function of GRB2 downstream of growth factor, cytokine, and
insulin receptors (3, 8). These proteins are critical for the initiation
and progression of human malignancies and other human diseases
(3, 8). These receptors transduce signals in a manner similar to the
TCR, although T cells induce signaling through separate kinase
and adaptor protein components (5, 10). The paradigm of the
field is that GRB2 solely facilitates the recruitment of downstream
effector signaling proteins. However, similar to TCR-induced LAT
oligomerization, EGF receptors cluster and form supramolecular
signaling structures that are critical for signal transduction (53).
Collectively, our studies identify a new paradigm of how GRB2 reg-
ulates the biology of T cells, but also highlight that GRB2 functions
both as an adaptor protein, where it localizes signaling proteins to
sites of active signaling, and a structural protein, where it facilitates
the clustering of receptors and adaptor proteins.
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